Jaime Roman-Pavajeau, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Katy, TXNPI 1396943296
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,820 of the $4,491 with a category attached, or 62.8%. 16 manufacturers reported payments, led by TELA Bio, Inc. at 52.5% of the total. That places this record below the midpoint for thoracic surgery (cardiothoracic vascular surgery) clinicians in TX, where the typical reported total is $5,866.
Across 44 payments — averaging $102.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- TELA Bio, Inc.$2K
- Solventum Corporation$2K
- Davol Inc.$89
- Medtronic$83
- Intuitive Surgical$63
- KCI USA, Inc.$54
- plus $251 from 10 others
What the payments were for
- Travel & lodging$2,82063%
- Food & beverage$1,67137%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| TELA Bio, Inc. | 13 | $2,360 |
| Solventum Corporation | 8 | $1,591 |
| Davol Inc. | 3 | $89 |
| Medtronic | 2 | $83 |
| Intuitive Surgical | 2 | $63 |
| KCI USA, Inc. | 3 | $54 |
| Integra Lifesciences Corporation | 2 | $41 |
| Atricure, Inc. | 1 | $39 |
| Smith+Nephew | 2 | $34 |
| Merck | 1 | $31 |
| Chiesi USA, Inc. | 2 | $27 |
| Boston Scientific | 1 | $24 |
| Kerecis Limited | 1 | $17 |
| Johnson & Johnson | 1 | $14 |
| Aroa Biosurgery Incorporated | 1 | $13 |
| Pacira Pharmaceuticals Incorporated | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,491 in reported general payments places this provider in the 45th percentile of 424 thoracic surgery (cardiothoracic vascular surgery) providers in Texas.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 27 | $673 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 28 | $136 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $107 |
| Tramadol Hcl | 29 | $44 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Katy
- Faraz KerendiAustin$906K
- Robert HebelerDallas$723K
- Michael ReardonHouston$713K
- Danny RamzyHouston$527K
- Scott OlssonCypress$357K
- Randall WolfHouston$283K
- Gary JettPlano$277K
- Darien BradfordBurleson$266K
- William BrinkmanPlano$266K
- Brannon HydeAustin$214K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.